Helping Patients Navigate the Disability Process. Professor JoNel Newman, J.D.

Size: px
Start display at page:

Download "Helping Patients Navigate the Disability Process. Professor JoNel Newman, J.D."

Transcription

1 Helping Patients Navigate the Disability Process Professor JoNel Newman, J.D.

2 Goals What is the Social Security standard for HIV disability? How can you facilitate patient care and assist patients in this process?

3 Documentation is Key Quality Patient Care Continuity of Care Patient Progress HIPAA Compliance Billing/Insurance Providers Avoiding Liability Public Health Record Patient Legal Claims

4 Documentation and Legal Claims Social Security Disability and Medicaid Claims Insurance Claims Employment- Related Disability Claims Other Legal Cases Where Relevant

5 Disability and Medical Providers Over 10% of Americans live with a severe disability. Medical providers play a key role in the outcome of a disability claim. Successful outcomes require medical case manager communication with the legal advocate, and welldocumented patient records, as well as specific evaluation forms. Often, a decision in a disability case determines whether a patient receives Medicaid and other insurance benefits.

6 Importance of Evaluations and Documentation Millions of people rely on disability benefits and insurance to survive. Most applicants are initially denied. On appeal, approximately 2/3s of the applicants are approved. The primary reason for denial at every stage is lack of medical evidence. Patients are responsible for providing medical evidence to prove disability.

7 Disability Defined The inability to engage in any substantial gainful activity due to any medically determinable physical or mental impairment A disabling condition which has lasted or can be expected to last for a period of at least 12 consecutive months or result in death A government agency (DOH or SSA) must find an individual is disabled

8 Previous Social Security HIV Listing AIDS defining condition, e.g.s: OR pneumocystis pneumonia, various bacterial, viral, fungal infections, skin conditions, Kaposi Sarcoma, severe diarrhea and dehydration, etc. repeated manifestations of HIV resulting in functional limitations.

9 January 1, 2017 Listing Moved away from AIDS - defining conditions, now: a serious HIV - related condition, a qualifying CD4 count, repeated hospitalizations, OR, as before, repeated manifestations of HIV.

10 Now, may qualify with an HIV diagnosis and one of four other conditions: 1. A serious HIV - related condition, such as: multicentric Castleman disease primary central nervous system lymphoma primary effusion lymphoma progressive multifocal leukoencephalopathy pulmonary Kaposi sarcoma

11 2. A low CD4 count - Either A CD4 of 50 or less Or A CD4 of 200 or less (or CD4 percentage of less than 14) PLUS BMI measurement of less than 18.5; OR Hemoglobin measurement of less than 8.0 grams per deciliter (g/dl)

12 3. Complication(s) of HIV infection requiring - At least three hospitalizations within a 12 - month period at least 30 days apart must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization

13 4. Repeated Manifestations: All those listed above but without requisite findings AND/OR Cardiovascular disease Diarrhea Distal sensory polyneuropathy Glucose intolerance Gynological conditions (e.g. PID, cervical cancer) Hepatitis HIV associated dementia IRIS Infections (bacterial, fungal, parasitic, viral) Lipodystrophy Malnutrition

14 4. Repeated Manifestations, cont d: Muscle weakness Myositis Neurocognitive or other mental limitations Oral hairy leukoplakia Osteoporosis Pancreatitis Peripheral neuropathy THAT RESULTS IN SIGNIFICANT DOCUMENTED SYMPTOMS, e.g.: fever, headaches, involuntary weight loss, malaise, nausea, night sweats, pain, severe fatigue, vomiting

15 4. Repeated Manifestations, cont d: Requires Conditions as listed above With Significant documented symptoms And One Marked 1. Limitation of activities of daily living 2. Limitation in maintaining social functioning 3. Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace.

16 Form SSA-4814 ( ) UF Discontinue Prior Editions Social Security Administration MEDICAL REPORT ON ADULT WITH ALLEGATION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION B. HOW WAS HIV INFECTION DIAGNOSED? C. CONDITIONS RELATED TO HIV INFECTION: Primary central nervous system lymphoma Primary effusion lymphoma Complication(s) of HIV infection requiring at least three hospitalizations within a 12-month period and at least 30 days apart. Complication of HIV Infection: Date of Hospitalization: Duration: Name of Hospital:

17 Does the patient show any of the following repeated manifestations related to his or her HIV infection? Cardiovascular disease Diarrhea Distal sensory polyneuropathy Glucose intolerance Gynecologic conditions Hepatitis HIV-associated dementia IRIS Infections (bacterial, fungal, parasitic, or viral) Lipodystrophy (lipoatrophy or lipohypertrophy) Malnutrition Muscle weakness Myositis Neurocognitive or other mental limitations Oral hairy leukoplakia Osteoporosis Pancreatitis Peripheral neuropathy Other:

18 If the patient shows any of the repeated manifestations above, are there significant, documented signs of these manifestations (for example, but not limited to, fever, headaches, insomnia, involuntary weight loss, malaise, nausea, night sweats, pain, severe fatigue, or vomiting)? No Yes If yes, please specify which signs are present? If the patient shows repeated manifestations of any of the above, does he or she also suffer from any of the following limitations at the marked level? Limitation of activities of daily living Limitation in maintaining social functioning Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace

19 Evaluation Forms Important to help facilitate evaluation forms being filled out. Ask the patient about how the medical condition affects him or her. Patient reports that is better than no response. Follow the evaluation form.

Paul Volberding, M.D. (Chair) Igor Grant, M.D., FRCP John G. Bartlett, M.D. H. Clifford Lane, M.D. Celia Maxwell, M.D., FACP Carlos del Rio, M.D.

Paul Volberding, M.D. (Chair) Igor Grant, M.D., FRCP John G. Bartlett, M.D. H. Clifford Lane, M.D. Celia Maxwell, M.D., FACP Carlos del Rio, M.D. HIV and Disability Committee membership Paul Volberding, M.D. (Chair) San Francisco VA Medical Center John G. Bartlett, M.D. Johns Hopkins University Carlos del Rio, M.D. Emory University Patricia M. Flynn,

More information

Clinical Manifestations of HIV

Clinical Manifestations of HIV HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from

More information

medical monitoring: clinical monitoring and laboratory tests

medical monitoring: clinical monitoring and laboratory tests medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify

More information

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005.

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005. HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning Bill Wade R.N June 21,2005. 1 Goals of this presentation Offer minimum content levels to enhance your learning needs around HIV/AIDS

More information

HIV: Disease Trajectory and Hospice Eligibility

HIV: Disease Trajectory and Hospice Eligibility HIV: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources/HEN Course Materials & Disclosure Course materials including handout(s) and conflict

More information

INTEGRATING HIV INTO PRIMARY CARE

INTEGRATING HIV INTO PRIMARY CARE INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.

More information

HIV: Disease Trajectory and Hospice Eligibility

HIV: Disease Trajectory and Hospice Eligibility HIV: Disease Trajectory and Hospice Eligibility Terri L. Maxwell, PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc Hospice Education Network Inc Course Handouts & Post Test To download presentation

More information

HIV/AIDS Definition: CDC Classification of HIV Infection Stage 1: Stage 2: Stage 3: Risk Factors

HIV/AIDS Definition: CDC Classification of HIV Infection Stage 1: Stage 2: Stage 3: Risk Factors HIV/AIDS Definition: Acquired immune deficiency syndrome (AIDS) is a progressive, incurable disease caused by the human immunodeficiency virus (HIV). Aids destroys the CD4+ T cells, impairing the immune

More information

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier

More information

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Monthly Nutritional Supplement (MNS)

Monthly Nutritional Supplement (MNS) d i s a b i l i t y a l l i a n c e b c 4 h e l p s h e e t 2018 b c d i s a b i l i t y b e n e f i t s Monthly Nutritional Supplement (MNS) This Help Sheet is funded by the Health Sciences Association

More information

227 28, 2010 MIDTERM EXAMINATION KEY

227 28, 2010 MIDTERM EXAMINATION KEY Epidemiology 227 April 28, 2010 MIDTERM EXAMINATION KEY Select the best answer for the multiple choice questions. There are 64 questions and 9 pages on the examination. Each question will count one point.

More information

INITIATING ART IN CHILDREN: Follow the six steps

INITIATING ART IN CHILDREN: Follow the six steps INITIATING ART IN CHILDREN: Follow the six steps STEP 1: DECIDE IF THE CHILD HAS CONFIRMED HIV INFECTION Child < 18 months: HIV infection is confirmed if the PCR is positive and the VL is more than 10,000

More information

H - Human. A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome

H - Human. A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome Definition of Terms H - Human A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome How is HIV Transmitted? Risk Behaviors Unprotected anal, oral, and vaginal intercourse Sharing

More information

Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC

Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC Lupus and Social Security Disability Programs LISA GONZALEZ GOETZ, PA GONZALEZ & GOETZ, LLC SOCIAL SECURITY DISABILITY PROGRAMS Disability Insurance Benefits (Title II) Supplemental Security Income (Title

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

HIV and Long Term Disability

HIV and Long Term Disability HIV and Long Term Disability Minnesota AIDS Project The Minnesota AIDS Project envisions a world free of AIDS. Our mission is to lead Minnesota's fight to stop HIV through advocacy, education, and service.

More information

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018 HIV/AIDS Communication and Prevention Davison Community Schools Grade Six June 2018 Discussing Sensitive Matters with Your Parents Parents: A child s first and most important teacher Parent s role is to

More information

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s

More information

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 Didactic Series Primary HIV Infection Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council

More information

Preventing Sexual Transmitted Diseases

Preventing Sexual Transmitted Diseases Preventing Sexual Transmitted Diseases Chapter 12 Card game Lie Sexually Transmitted Diseases Sexuality is an intrinsic part of human nature and affects many things People are not always honest about their

More information

An Important Message for Patients and Healthcare Professionals Who Depend on IMBRUVICA (ibrutinib)

An Important Message for Patients and Healthcare Professionals Who Depend on IMBRUVICA (ibrutinib) An Important Message for Patients and Healthcare Professionals Who Depend on IMBRUVICA (ibrutinib) IMBRUVICA (ibrutinib) is a meaningful and important treatment option for patients with chronic lymphocytic

More information

CERTIFICATION OF ENROLLMENT ENGROSSED SUBSTITUTE SENATE BILL th Legislature 2007 Regular Session

CERTIFICATION OF ENROLLMENT ENGROSSED SUBSTITUTE SENATE BILL th Legislature 2007 Regular Session CERTIFICATION OF ENROLLMENT ENGROSSED SUBSTITUTE SENATE BILL 6032 60th Legislature 2007 Regular Session Passed by the Senate April 20, 2007 YEAS 37 NAYS 9 President of the Senate Passed by the House April

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

Running Head: HIV/AIDS 1. Medical Nutrition Therapy and HIV

Running Head: HIV/AIDS 1. Medical Nutrition Therapy and HIV Running Head: HIV/AIDS 1 Medical Nutrition Therapy and HIV HIV/AIDS 2 Medical Nutrition Therapy and HIV Introduction Mr. W is in the last stage of HIV AIDS. He visited the rehabilitation program last year.

More information

5 th Grade Curriculum HIV and Communicable Diseases

5 th Grade Curriculum HIV and Communicable Diseases 5 th Grade Curriculum HIV and Communicable Diseases HIV and Communicable Diseases Serious subject Mature enough Consequences Informational Prevention Hypochondriac Disease HIV-AIDS HIV Human Immunodeficiency

More information

Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)

Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) STI s once called venereal diseases More than 20 STIs have now been identified most prevalent among teenagers and young adults.

More information

Understanding THE SYMPTOMS YOU SEE

Understanding THE SYMPTOMS YOU SEE Understanding THE SYMPTOMS YOU SEE Z Human existence is rich with experiences that weave a completed quilt called life. As the quilt nears completion, there is no set calendar as to its final, beautiful

More information

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Agenda 1. HIV and the immune system 2. The progression of untreated HIV 3. Monitoring

More information

The Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Bloomberg School of Public Health The Johns Hopkins Bloomberg School of Public Health CONSENT FORM A / NEW RESEARCH PROJECT Title of Research Project: A Randomized Trial of HAART in Acute/Early HIV Infection Version 3.0 Principal Investigator:

More information

MYTHS OR FACTS OF STI s True or False

MYTHS OR FACTS OF STI s True or False Viral STI s MYTHS OR FACTS OF STI s True or False 1. There is no cure for herpes or AIDS. 2. Condoms protect against STI s. 3. If two people are free from STI s and have no other sexual partners, they

More information

How is it transferred?

How is it transferred? STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live

More information

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication For Healthcare Providers About TRUVADA for a PrEP Indication INDICATION AND PRESCRIBING CONSIDERATIONS TRUVADA,

More information

GOALS AND OBJECTIVES INFECTIOUS DISEASE

GOALS AND OBJECTIVES INFECTIOUS DISEASE GOALS AND OBJECTIVES INFECTIOUS DISEASE Infectious Disease and HIV Overview: The Infectious Diseases Program at the University of Southern California prepares trainees for the management of problems in

More information

Medical monitoring: tests available at central hospitals

Medical monitoring: tests available at central hospitals medial monitoring: tests available at central hospitals: 1 medical monitoring: tests available at central hospitals Medical monitoring: tests available at central hospitals medial monitoring: tests available

More information

Broward Oncology Associates, P.A. PATIENT INFORMATION

Broward Oncology Associates, P.A. PATIENT INFORMATION NAME: BIRTHDATE: AGE: LOCAL ADDRESS (Street city state zip): HOME TELEPHONE# CELL # SOCIAL SECURITY #: - - SEX MARITAL STATUS WHAT IS YOUR HT? WHAT IS YOUR WT? EMPLOYER WORK# SPOUSE'S NAME SPOUSE'S EMPLOYER

More information

Authorization for vaccination

Authorization for vaccination FOR USE BY CLSC INFORMATION RELATING TO VACCINATION Free Vaccination programs File no FIRST dose in grade 4 elementary school CONTRAINDICATION TO VACCINATION (specify) You must fill out the vaccination

More information

Efavirenz, stavudine and lamivudine

Efavirenz, stavudine and lamivudine efavirenz, stavudine, lamivudine: 1 efavirenz, stavudine and lamivudine First line ART treatment for HIV infection Efavirenz, stavudine and lamivudine efavirenz, stavudine, lamivudine: 2 Slide 1 Information

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs Additional copies of this guidance are available from the Office

More information

Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus

Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus Safety of Treatment in Cirrhotics in the Era of New Antiviral Therapies for Hepatitis C Virus JEFFREY NADELSON MD, ALAN EPSTEIN MD, THOMAS SEPE MD BOSTON UNIVERSITY SCHOOL OF MEDICINE ROGER WILLIAMS MEDICAL

More information

STI Feud Instructions

STI Feud Instructions STI Feud Instructions This game works best with groups of 4 20. What you will need: The STI question cards, 2 easy buttons from staples, chart paper, markers (if no black or white board) 1. Break the group

More information

May He Rest in Peace

May He Rest in Peace May He Rest in Peace Neurologic Complications of AIDS Medical Knowledge Fiesta 2012 Paul K. King MD pkingmd@yahoo.com Objectives definition of HIV/AIDS what are the neurologic complications of AIDS how

More information

Disclosure. Learner Objectives. Congenital Infections. Question. Main Categories 4/26/2016

Disclosure. Learner Objectives. Congenital Infections. Question. Main Categories 4/26/2016 Communicating Communicability: Imaging of CNS Infections Aaron P. Kamer, MD Assistant Professor of Clinical Radiology Neuroradiology Section April 26, 2016 Disclosure Within the past 12 months: I have

More information

New Patient Information

New Patient Information Geoffrey G Glidden MD PA New Patient Information Name Address City/State/Zip Cell Phone Home Phone DL# SSN# Age of Birth Sex: Male / Female Your employer Occupation Work Phone E-Mail Referring Physician

More information

3. Does the patient meet ALL of the following requirements? Y N

3. Does the patient meet ALL of the following requirements? Y N Pharmacy Prior Authorization AETA BETTER HEALTH FLORIDA Procrit - Retacrit (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign

More information

Alzheimer s Disease, Dementia, Related Disorders

Alzheimer s Disease, Dementia, Related Disorders Alzheimer s Disease, Dementia, Related Disorders Stage 7 on the FAST Scale signifies the threshold of activity limitation that would support a six-month prognosis. The FAST Scale does not address the impact

More information

MEDICAL ASSESSMENT PART 1 - SOCIAL HISTORY

MEDICAL ASSESSMENT PART 1 - SOCIAL HISTORY Smoking history Alcohol history Never Quit Never Quit PART 2 - MEDICAL HISTORY Date of last colonoscopy? Date of last mammogram? Date of last pap smear? Date of last flu vaccine? Date of last pneumonia

More information

Doctor, I Have Strep Throat. Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018

Doctor, I Have Strep Throat. Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018 Doctor, I Have Strep Throat Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018 Disclosures None The Patient: 41YOF CC: Sore throat x 3 days HPI: Sore throat increasing

More information

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1

Past Medical History. Chief Complaint: Patient Name: Appointment Date: Page 1 Appointment Date: Page 1 Chief Complaint: (Please write reason, symptoms, condition or diagnosis that prompts your appointment) Past Medical History PERSONAL SKIN HISTORY YES NO Yes - Details Melanoma

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

guide to living with cancer Brought to you by Alliance Health.

guide to living with cancer Brought to you by Alliance Health. guide to living with cancer Brought to you by Alliance Health. The content in this guide is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice

More information

Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma

Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Indication: Treatment of patients with Cutaneous Lymphoma (Unlicensed use) Disease control prior to Reduced Intensity Conditioning Stem Cell Transplant

More information

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology REVIEWED DATE / INITIALS Safety: Are you at risk for falls? Do you have a Pacemaker? Females; Is there a possibility you may be pregnant? Allergies: If YES, please list medication allergies: Do you have

More information

DEFENSE HEALTH AGENCY 7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS CHURCH, VIRGINIA

DEFENSE HEALTH AGENCY 7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS CHURCH, VIRGINIA DEFENSE HEALTH AGENCY 7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS CHURCH, VIRGINIA 22042-5101 DHA-IPM 18-020 MEMORANDUM FOR ASSISTANT SECRETARY OF THE ARMY (MANPOWER AND RESERVE AFFAIRS) ASSISTANT SECRETARY

More information

ABC/3TC/ZDV ABC PBO/3TC/ZDV

ABC/3TC/ZDV ABC PBO/3TC/ZDV The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Corner on Wellness Chiropractic Center Therapeutic Massage

Corner on Wellness Chiropractic Center Therapeutic Massage Corner on Wellness Chiropractic Center Therapeutic Massage Patient Name Date Address _ City State Zip Phone Email Emergency Contact Name Phone Employer Work Phone Date of Birth Social Security # Is condition

More information

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology REVIEWED DATE / INITIALS Safety: Yes No Are you at risk for falls? Do you have a Pacemaker? Females; Is there a possibility you may be pregnant? Allergies: Yes No If YES, please list medication allergies:

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

HIV MANAGEMENT PROGRAMME APPLICATION FORM

HIV MANAGEMENT PROGRAMME APPLICATION FORM Private Private Bag X82081, Bag X82081, Rustenburg, Rustenburg, 0300 0300 Tel: Tel: (014) 590 5901700 1900 Fax: Fax: 086 (014) 577 0274 591 4570 www.platinumhealth.co.za www.platinumhealth.co.za ZZGPlatinumHealthClinicalMotivation@angloamerican.com

More information

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection MabThera SC. The wait is over. MabThera delivered in just 5 minutes Abbreviated Prescribing Information MabThera 1400 mg solution for subcutaneous (SC) injection (Rituximab) Indications: Indicated in adults

More information

OUTCOME CODES FOR MACS STATUS FORM

OUTCOME CODES FOR MACS STATUS FORM OUTCOME CODES FOR MACS STATUS FORM CODE CDC-DEFINED AIDS DIAGNOSES (Section C) 01 Kaposi's sarcoma 02 Pneumocystis carinii pneumonia 03 Toxoplasmosis (at a site other than or in addition to liver, spleen,

More information

LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS

LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS LTASEX.INFO! IN AIDS is a treatable complication of advanced HIV infection.

More information

IRB Approval From: 3/8/2010 To: 10/28/2010

IRB Approval From: 3/8/2010 To: 10/28/2010 UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 (Version 3.0, 16 FEB 2010) IRB Approval From:

More information

CE Unit. Viruses and Vaccines

CE Unit. Viruses and Vaccines CE Unit Viruses and Vaccines DO NOT WRITE What is a virus? Have you ever had a virus? What is a vaccine? How is a virus different from bacteria? What are the deadliest viruses? 10. Dengue fever 50 million

More information

Nursing Interventions

Nursing Interventions Chapter 16 H I Human Immunodeficiency V Virus A Acquired I Immuno D Deficiency S Syndrome Slide 1 Nursing Interventions Duty to treat Health care professionals may not pick and choose their patients Rehabilitation

More information

ADVANCED GASTROENTEROLOGY & ENDOSCOPY, P.C. ALI S. KARAKURUM, MD, FACP, FACG

ADVANCED GASTROENTEROLOGY & ENDOSCOPY, P.C. ALI S. KARAKURUM, MD, FACP, FACG ADVANCED GASTROENTEROLOGY & ENDOSCOPY, P.C. ALI S. KARAKURUM, MD, FACP, FACG DATE SOC. SEC. NUMBER FULL NAME DATE OF BIRTH ADDRESS: STREET TOWN STATE ZIP PHONE: HOME WORK CELL EMPLOYER OCCUPATION ADDRESS

More information

Objectives 2/11/2016 HOSPICE 101

Objectives 2/11/2016 HOSPICE 101 HOSPICE 101 Overview Hospice History and Statistics What is Hospice? Who qualifies for services? Levels of Service The Admission Process Why Not to Wait Objectives Understand how to determine hospice eligibility

More information

Nuclear Medicine in HIV Update with FDG PET

Nuclear Medicine in HIV Update with FDG PET Nuclear Medicine in HIV Update with FDG PET Mike Sathekge, MB ChB, M Med (Nucl Med), PhD HOD: University of Pretoria Introduction Outline Brief about general nuclear medicine FDG in HIV: Update & Potential

More information

GAZYVA for Chronic Lymphocytic Leukemia (CLL)

GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA for Chronic Lymphocytic Leukemia (CLL) GAZYVA is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous

More information

Lymphatic System Disorders

Lymphatic System Disorders Lymphatic System Disorders Lymphomas Malignant neoplasms involving lymphocyte proliferation in lymph nodes Specific causes not identified // Higher risk in adults who received radiation during childhood

More information

MODULE 3 FLORIDA DEPARTMENT OF HEALTH STUDY GUIDE HIV/AIDS: 101 WEMAKETHECHANGE.COM

MODULE 3 FLORIDA DEPARTMENT OF HEALTH STUDY GUIDE HIV/AIDS: 101 WEMAKETHECHANGE.COM MODULE 3 FLORIDA DEPARTMENT OF HEALTH STUDY GUIDE HIV/AIDS: 101 WEMAKETHECHANGE.COM MODULE 3 SERVICE NEEDS FOR HIV-INFECTED INDIVIDUALS There are compelling personal and public health benefits to getting

More information

BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES DECISION

BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES DECISION BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES In the Matter of: ) ) B N ) OAH No. 15-1051-MDX ) Agency No. I. Introduction DECISION The

More information

Limitations & Restrictions Associated with Chronic Pain

Limitations & Restrictions Associated with Chronic Pain CANADIAN UNION OF PUBLIC EMPLOYEES Limitations & Restrictions Associated with Chronic Pain WorkSafeBC ( WCB ) Questionnaire Tom McKenna, National Representative, WCB Advocacy 1/23/2015 This information

More information

IRB Approval - 2/16/10-9/14/10

IRB Approval - 2/16/10-9/14/10 UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Tibotec Therapeutics Clinical Affairs, A Division of Centocor Ortho Biotech Services, LLC. TMC114HIV4023, Amendment 2 Version 18-FEB-2009 A multicenter, open-label,

More information

Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment

Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment Drug Resistant Tuberculosis Self-reporting of Drugrelated Adverse Events During Treatment Introduction This information has been prepared for people with tuberculosis (TB) that is resistant to the commonly

More information

BLOCK 12 Viruses of the ENT

BLOCK 12 Viruses of the ENT BLOCK 12 Viruses of the ENT Acute infections Introduction Pharyngitis, Common cold, Sinusitis, Otitis media Recurrent infections Herpes zoster oticus Chronic infections HIV and ENT manifestations Neoplasms

More information

Many people are confused about what Social Security benefits might be available to them. Here are answers to frequently asked questions.

Many people are confused about what Social Security benefits might be available to them. Here are answers to frequently asked questions. Many people are confused about what Social Security benefits might be available to them. Here are answers to frequently asked questions. What is the difference between SSI and SSDI? SSDI or Social Security

More information

Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont

Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont Controversy One: Headache and Disability Robert Shapiro, MD, PhD University of Vermont Southern Headache Society Orlando, FL, Sept 21, 2013 Disclosures Consulting within the past 12 months: Transcept Pharmaceuticals

More information

Definitions. Appendix A

Definitions. Appendix A Definitions Appendix A 1. Blood means human blood, human blood components, and products made from human blood. 2. Bloodborne Pathogens means pathogenic microorganisms that are present in human blood and

More information

Sexually Transmi/ed Diseases

Sexually Transmi/ed Diseases Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human

More information

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 John F. White III, MD, MBA, FLMI VP and Medical Director American National Insurance Company 1 Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 2 1 3 My Opinions

More information

Richmond Office 4718 National Rd. E. Richmond, IN

Richmond Office 4718 National Rd. E. Richmond, IN You have an appointment at Allergy & Asthma Care at the following address: Richmond Office 4718 National Rd. E. Richmond, IN 47374 765.966.0390 765.966.3343 You can visit our website at www.allergy-asthmacare.com

More information

BOTHELL INTEGRATED HEALTH, LLC Therapeutic Massage

BOTHELL INTEGRATED HEALTH, LLC Therapeutic Massage BOTHELL INTEGRATED HEALTH, LLC Therapeutic Massage Patient Name Date Address City State Zip Phone (home) (cell) Emergency Contact Name Phone Employer Date of Birth Work Phone Social Security # Is condition

More information

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University

More information

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil

More information

The Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University

The Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate

More information

Where is your pain located? Please use the diagram below to indicate where most of your pain is located.

Where is your pain located? Please use the diagram below to indicate where most of your pain is located. Name: Address: Social Security Number: Email Address: Emergency Contact: Primary Care Physician: Name: Address: Phone Number: Date of Birth: Today's date: Cell Phone Number: Phone #: Referring Physician:

More information

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment GAZYVA is a prescription medicine used with the chemotherapy drug, bendamustine, followed by GAZYVA alone for follicular

More information

The ORENCIA (abatacept) JIA Observational Registry

The ORENCIA (abatacept) JIA Observational Registry Moderate to Severe Juvenile Idiopathic Arthritis (JIA) Injection for Intravenous Use Injection for Subcutaneous Use The ORENCIA (abatacept) JIA Observational Registry Injection for Intravenous Use Injection

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients

More information

http://www.savinglivesuk.com/ HIV Awareness Study Morning 24 th November 2017 Agenda HIV Basics & Stages of HIV HIV Testing, Health Advising & Sexual Health Saving Lives Antiretroviral Medication Antenatal/Postnatal

More information

Case 1: Clinical Presentation

Case 1: Clinical Presentation Impostors and Preconceived Notions: Lessons Learned in TB Diagnosis & Treatment Tuberculosis Nursing Workshop June 1, 2015 Christopher Spitters, MD, MPH Tuberculosis Clinic Public Health Seattle & King

More information

Initial Consultation

Initial Consultation Today s Date: Initial Consultation Thank you for choosing Apollo Health and Wellness. Please take your time to fill out this form. It will help us to concentrate on areas of your health that need attention

More information

Non-covered ICD-10-CM Codes for All Lab NCDs

Non-covered ICD-10-CM Codes for All Lab NCDs Non-covered ICD-10-CM s for All Lab NCDs This section lists codes that are never covered by Medicare for a diagnostic lab testing service. If a code from this section is given as the reason for the test,

More information

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective:

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: GSK Medicine: abacavir (ABC)/dolutegravir (DTG)/lamivudine (3TC) Study Number: 201147 Title: A IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose

More information

Infergen Monotherapy. Infergen (interferon alfacon-1) Description

Infergen Monotherapy. Infergen (interferon alfacon-1) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.03.03 Subject: Infergen Monotherapy Page: 1 of 7 Last Review Date: March 13, 2014 Infergen Monotherapy

More information

BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES DECISION

BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES DECISION BEFORE THE ALASKA OFFICE OF ADMINISTRATIVE HEARINGS ON REFERRAL BY THE COMMISSIONER OF HEALTH AND SOCIAL SERVICES In the Matter of: ) ) D T ) OAH No. 15-1115-MDX ) Agency No. I. Introduction DECISION The

More information

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection.

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection. TRUVADA for PrEP is a prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices. TRUVADA for PrEP is only for people

More information

4. Pertinent physical findings including: a. Results of tests performed on patient, including dates and specific findings:

4. Pertinent physical findings including: a. Results of tests performed on patient, including dates and specific findings: Medical Assessment Form Patient: SSN: Please answer each of the following questions about the patient. They concern the patient s claim of entitlement to disability benefits under the Social Security Act.

More information

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis

More information